News Daily News Periprocedural MI Signals Worse Outcomes in Stented NSTE ACS Patients: MATRIX Michael O'Riordan January 15, 2026
News Daily News Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS Todd Neale October 03, 2025
News Daily News Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza Todd Neale July 25, 2025
News Daily News What’s the Damage With Long COVID? Advanced Imaging Reveals Clues Caitlin E. Cox May 27, 2025
News Daily News High-Sensitivity Troponin Tests Might Aid in Primary Prevention Yael L. Maxwell April 16, 2025
News Daily News Early Invasive Treatment May Help Highest-Risk Women With NSTE ACS Yael L. Maxwell March 10, 2025
News Daily News Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time Michael O'Riordan February 13, 2025
News Daily News Inconsistent Troponin Testing in US EDs Warrants Closer Look Todd Neale January 28, 2025
News Daily News Level of Consciousness After Cardiac Arrest Correlates With Post-PCI Outcomes Yael L. Maxwell October 25, 2024
News Daily News Heart Failure and Cancer: HFSA Statement Explores the Interplay Caitlin E. Cox October 24, 2024
News Daily News Universal Risk Tool Works Well in Both Primary and Secondary Prevention Michael O'Riordan February 01, 2024
News Daily News Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help Todd Neale January 11, 2024
News Daily News Who Benefits Most From Semaglutide and How Long Will That Take? Shelley Wood December 19, 2023
News Daily News AI-ECG Model Outperforms STEMI Criteria for Identifying ACS Patients With Occlusions Todd Neale December 08, 2023
News Daily News High-Sensitivity Troponins May Overestimate PE Severity L.A. McKeown November 28, 2023
News Daily News Congestion Biomarker CA125 Signals Worse Outcomes in Ambulatory HFrEF Todd Neale July 03, 2023
News Daily News Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA Michael O'Riordan May 03, 2023
News Daily News Moderate-Intensity Exercise Possible For Patients With Statin Side Effects Michael O'Riordan April 03, 2023